# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Orgenesis (NASDAQ:ORGS) reported quarterly losses of $(0.29) per share. This is a 270.59 percent decrease over earnings of $0.1...
- SEC Filing
Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (NASDAQ:ORGS), a global lead...